Literature DB >> 10341850

Cardiovascular disease and risk factors in adults with hypopituitarism.

S A Beshyah1, D G Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10341850     DOI： 10.1046/j.1365-2265.1999.00682.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  15 in total

Review 1.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

3.  Carotid atheromatic plaque is commonly associated with hypopituitary men.

Authors:  Joo Young Kim; Jae Won Hong; Sang Youl Rhee; Chul Sik Kim; Dae Jung Kim; Eun Jig Lee
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

Review 4.  Aetiology, diagnosis, and management of hypopituitarism in adult life.

Authors:  V K B Prabhakar; S M Shalet
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

Review 5.  Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence.

Authors:  William Jeffcoate
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

7.  Systemic hypertension counteracts potential benefits of growth hormone replacement therapy on left ventricular remodeling in adults with growth hormone deficiency.

Authors:  C de Gregorio; L Curtò; F Marini; G Andò; O Trio; F Trimarchi; S Coglitore; S Cannavò
Journal:  J Endocrinol Invest       Date:  2012-10-15       Impact factor: 4.256

8.  Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency.

Authors:  Maria Claudia Peixoto Cenci; Débora Vieira Soares; Luciana Diniz Carneiro Spina; Rosane Resende de Lima Oliveira Brasil; Priscila Marise Lobo; Vera Aleta Mansur; Jaime Gold; Eduardo Michmacher; Mario Vaisman; Flávia Lúcia Conceição
Journal:  Pituitary       Date:  2009-04-24       Impact factor: 4.107

9.  Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency.

Authors:  N Ozbey; A Telci; U Cakatay; A Yurci; S Molvalilar
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

10.  Low-dose growth hormone is cardioprotective in uremia.

Authors:  Ralph Rabkin; Ibrahim Awwad; Yu Chen; Euan A Ashley; Difei Sun; Sumita Sood; William Clusin; Paul Heidenreich; Grzegorz Piecha; Marie-Luise Gross
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.